Iritero 40mg Injection
Marketer
Hetero Drugs Ltd
Salt Composition
Irinotecan (40mg)
Overview Iritero 40mg Injection
Colontox 40mg injection is indicated for colorectal cancer. Its mechanism of action involves inhibiting or reducing the proliferation of cancerous cells. Administration is via intravenous infusion by a healthcare professional. Dosage and frequency are determined by your physician based on individual needs and may vary. Strict adherence to your doctor's instructions is crucial; improper use or overdose can lead to severe adverse reactions. Therapeutic effects might not be immediately apparent, potentially taking weeks or months; discontinue only under medical supervision. Common side effects include tiredness, queasiness, emesis, debility, and alopecia. This medication can lower blood cell counts (red and white), raising infection risk. Report fever, pharyngitis, and persistent diarrhea to your doctor immediately. Regular blood tests are necessary to monitor blood cell levels, along with cardiac, hepatic, and uric acid parameters. Prior to treatment, disclose any pre-existing heart, liver, or kidney conditions, and all current medications, particularly anti-infectives, as drug interactions are possible. This medication is contraindicated during pregnancy and lactation. Reliable contraception for both partners is essential throughout treatment to prevent conception.
Uses of Iritero 40mg Injection
Colorectal cancer
Major Benefits of Iritero 40mg Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Iritero 40mg Injection:
- Fatigue
- Nausea
- Vomiting
- Weakness
- Hair loss
- Fever
- Anemia (low number of red blood cells)
- Diarrhea
- Decreased white blood cell count (neutrophils)
- Decreased appetite
- Mucosal inflammation
How to use Iritero 40mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Iritero 40mg Injection works:
Iritero 40mg Injection is an anticancer drug that inhibits topoisomerase I, an enzyme crucial for cancer cell DNA replication. This inhibition restricts cancer cell proliferation, ultimately leading to their demise.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Iritero 40mg Injection may pose unknown risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Iritero 40mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. Exceptions may exist in extreme circumstances where a physician deems the potential benefits outweigh the known hazards. Always seek medical advice before use.
Breast feedingUNSAFE
Administering Iritero 40mg Injection while breastfeeding is contraindicated. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
The 40mg Iritero injection can cause drowsiness, blurred vision, and dizziness, potentially impairing alertness. Refrain from driving while experiencing these effects.
KidneySAFE IF PRESCRIBED
The 40mg Iritero Injection is likely safe for individuals with kidney impairment. Current evidence indicates dose modification may be unnecessary; however, medical consultation is advised. This medication is contraindicated for dialysis patients.
LiverCONSULT YOUR DOCTOR
Data regarding Iritero 40mg Injection's use in individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Iritero 40mg Injection :
Omit Iritero 40mg Injection doses only after contacting your physician for guidance.
Facts to Know About Iritero 40mg Injection
| Label | Value |
|---|---|
| Chemical Type | Camptothecin Analog |
| Developing Habits | No. |
| Treatment Category | Cancer Medications |
| Behavior Class | Topoisomerase inhibitor |
3,018 People bought this recently